For: | Hu WS, Jiang FY, Shu W, Zhao R, Cao JM, Wang DP. Liver injury in COVID-19: A minireview. World J Gastroenterol 2022; 28(47): 6716-6731 [PMID: 36620342 DOI: 10.3748/wjg.v28.i47.6716] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i47/6716.htm |
Number | Citing Articles |
1 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|
2 |
Rolf Teschke, Axel Eickhoff. Features, Transmission, Detection, and Case Studies in COVID-19. 2024; : 267 doi: 10.1016/B978-0-323-95646-8.00047-0
|
3 |
Samuel Stróż, Piotr Kosiorek, Anna Stasiak-Barmuta. The COVID-19 inflammation and high mortality mechanism trigger. Immunogenetics 2024; 76(1): 15 doi: 10.1007/s00251-023-01326-4
|
4 |
Xiaoqing Xu, Yue Wu, Yongxia Zhao, Aimei Liu, Chenyang Yi, Anding Zhang, Xu Wang. Inhibition of Macrophage Pyroptosis─A New Therapeutic Strategy to Alleviate T-2 Toxin-Induced Subacute Liver Injury by Directly Competing with the Key Target. Journal of Agricultural and Food Chemistry 2024; 72(33): 18670 doi: 10.1021/acs.jafc.4c03340
|
5 |
Xinghai Li, Caiping Fan, Jin Tang, Ning Zhang. Meta-analysis of liver injury in patients with COVID-19. Medicine 2023; 102(29): e34320 doi: 10.1097/MD.0000000000034320
|